Oncology Institute insider reports 9,852,944 shares

Oncology Institute, Inc. filed an initial insider ownership report showing that major shareholder Jorey Chernett beneficially owns 9,852,944 shares of the company’s common stock.

Rhea-AI Filing Summary

Oncology Institute, Inc. filed an initial insider ownership report showing that major shareholder Jorey Chernett beneficially owns 9,852,944 shares of the company’s common stock. These shares are reported as held directly, reflecting an existing position rather than a new purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Chernett Jorey

Role 10% Owner

Type	Security	Shares	Price	Value
holding	Common Stock, $0.0001 Par Value	--	--	--

Holdings After Transaction: Common Stock, $0.0001 Par Value — 9,852,944 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing by Jorey Chernett for TOI show?

The Form 3 shows that major shareholder Jorey Chernett beneficially owns 9,852,944 shares of Oncology Institute, Inc. common stock. It is an initial ownership report, not a record of new share purchases or sales.

How many Oncology Institute (TOI) shares does Jorey Chernett report owning?

Jorey Chernett reports beneficial ownership of 9,852,944 shares of Oncology Institute common stock. This large stake makes Chernett a ten percent owner, as reflected in the Form 3 insider ownership filing.

Is the ownership reported by Jorey Chernett in TOI held directly or indirectly?

The ownership is reported as direct, meaning the 9,852,944 Oncology Institute common shares are held in Chernett’s own name rather than through a trust, partnership, or other indirect entity structure.

Does the TOI Form 3 filing indicate recent insider buying or selling by Jorey Chernett?

The Form 3 does not indicate recent buying or selling activity. It classifies the entry as a holding, simply establishing Chernett’s existing beneficial ownership of 9,852,944 Oncology Institute common shares.

Why is Jorey Chernett classified as a ten percent owner of TOI?

Chernett is classified as a ten percent owner because the reported beneficial stake is large relative to Oncology Institute’s equity. Form 3 requires such major shareholders to disclose their holdings when they cross specified ownership thresholds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 08:32 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chernett Jorey

(Last) (First) (Middle)

6222 INDIANWOOD TR.

(Street)

BLOOMFIELD HILLS MI 48301

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/13/2026

3. Issuer Name and Ticker or Trading Symbol
Oncology Institute, Inc. [ TOI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $0.0001 Par Value	9,852,944	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jorey Chernett	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.